Scribe Biosciences Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Out of Business

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Out of Business

  • Investors
  • 1

Scribe Biosciences General Information

Description

Developer of single-cell analysis tools designed to provide development in clinical and research applications. The company's tools use printed droplet microfluidics to perform picoliter-scale manipulations by leveraging fluorescence-activated microfluidic droplet sorting and a specialized substrate, enabling doctors to gain knowledge and develop studies for processes in infectious cancer diseases.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 953 Indiana Street
  • San Francisco, CA 94107
  • United States
Primary Industry
Other Devices and Supplies
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 953 Indiana Street
  • San Francisco, CA 94107
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Scribe Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Out of Business 12-Feb-2025 Completed Generating Revenue
12. Grant 10-Aug-2023 Completed Generating Revenue
11. Accelerator/Incubator 01-Jun-2023 Completed Generating Revenue
10. Accelerator/Incubator 22-May-2023 Completed Generating Revenue
9. Grant 07-Sep-2022 Completed Generating Revenue
8. Early Stage VC 01-Dec-2021 Completed Generating Revenue
7. Early Stage VC 01-May-2021 Completed Generating Revenue
6. Grant 07-Feb-2020 Completed Generating Revenue
5. Grant 01-Jan-2020 $225K Completed Generating Revenue
4. Grant 01-Jan-2019 $575K Completed Generating Revenue
To view Scribe Biosciences’s complete valuation and funding history, request access »

Scribe Biosciences Patents

Scribe Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023183461-A1 Microfluidic cartridges Inactive 24-Mar-2022
US-20230250468-A1 Homogenous assays in microdroplets Inactive 18-Jan-2022
US-20230016357-A1 Deterministic hybridoma generation via microfluidics Inactive 10-Mar-2021
US-20230159878-A9 Deterministic hybridoma generation via microfluidics Inactive 10-Mar-2021
US-20220106631-A1 Barcoding in droplets for cell-cell interaction and secreted protein detection and analysis Inactive 05-Oct-2020 C12Q1/6804
To view Scribe Biosciences’s complete patent history, request access »

Scribe Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Scribe Biosciences Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
UCSF Innovation Ventures Venture Capital Minority
To view Scribe Biosciences’s complete investors history, request access »

Scribe Biosciences FAQs

  • When was Scribe Biosciences founded?

    Scribe Biosciences was founded in 2017.

  • Where is Scribe Biosciences headquartered?

    Scribe Biosciences is headquartered in San Francisco, CA.

  • What is the size of Scribe Biosciences?

    Scribe Biosciences has 4 total employees.

  • What industry is Scribe Biosciences in?

    Scribe Biosciences’s primary industry is Other Devices and Supplies.

  • Is Scribe Biosciences a private or public company?

    Scribe Biosciences is a Private company.

  • What is Scribe Biosciences’s current revenue?

    The current revenue for Scribe Biosciences is .

  • How much funding has Scribe Biosciences raised over time?

    Scribe Biosciences has raised $250K.

  • Who are Scribe Biosciences’s investors?

    UCSF Innovation Ventures has invested in Scribe Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process